Weight Gain Management in Patients With Schizophrenia

NCT00486005 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Olanzapine Hydrochloride
DRUG: Nizatidine
DRUG: Placebo

Sponsor

Eli Lilly and Company